In the past week, NLSP stock has gone down by -0.29%, with a monthly decline of -23.73% and a quarterly plunge of -23.97%. The volatility ratio for the week is 13.41%, and the volatility levels for the last 30 days are 10.49% for NLS Pharmaceutics Ltd The simple moving average for the past 20 days is -6.31% for NLSP’s stock, with a -49.09% simple moving average for the past 200 days.
Is It Worth Investing in NLS Pharmaceutics Ltd (NASDAQ: NLSP) Right Now?
Additionally, the 36-month beta value for NLSP is -0.57. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for NLSP is 29.84M and currently, short sellers hold a 3.98% ratio of that float. The average trading volume of NLSP on September 24, 2024 was 5.84M shares.
NLSP) stock’s latest price update
The stock price of NLS Pharmaceutics Ltd (NASDAQ: NLSP) has dropped by -10.20 compared to previous close of 0.15. Despite this, the company has seen a fall of -0.29% in its stock price over the last five trading days. benzinga.com reported 2024-07-29 that U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 0.4% on Monday.
NLSP Trading at -22.99% from the 50-Day Moving Average
After a stumble in the market that brought NLSP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.64% of loss for the given period.
Volatility was left at 10.49%, however, over the last 30 days, the volatility rate increased by 13.41%, as shares sank -22.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.79% lower at present.
During the last 5 trading sessions, NLSP fell by -0.29%, which changed the moving average for the period of 200-days by -75.37% in comparison to the 20-day moving average, which settled at $0.1427. In addition, NLS Pharmaceutics Ltd saw -77.01% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NLSP
The total capital return value is set at 1.94.
Based on NLS Pharmaceutics Ltd (NLSP), the company’s capital structure generated -0.23 points at debt to capital in total, while cash flow to debt ratio is standing at -5.93. The debt to equity ratio resting at -0.18. The interest coverage ratio of the stock is -81.34.
Currently, EBITDA for the company is -11.8 million with net debt to EBITDA at -0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.23.
Conclusion
In conclusion, NLS Pharmaceutics Ltd (NLSP) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
